![](/img/cover-not-exists.png)
THU0282 Clinical efficacy to a second anti-tnf therapy is associated with the development of antibodies against the first anti-TNF therapy in patients with spondyloartrhitis
Garcia Carazo, S., Plasencia, C., Pascual Salcedo, D., Bonilla Hernan, G., Lojo, L., Villalba, A., Nuno, L., del Olmo, L., Gil Barato, S., Alcocer Amores, P., Arribas, F., Perez, E., Martin Mola, E.,Volume:
71
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-eular.2247
Date:
June, 2012
File:
PDF, 91 KB
english, 2012